Emergency Medicine Doctors in South Portland, ME Accepting Medicare

9 Emergency Medicine doctors found. Showing 1 - 9

Dr. Robert B Abrahamsen, M.D. Emergency Medicine - Undersea and Hyperbaric Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Western Ave, Suite 100, South Portland, ME 04106 Phone: 207-772-1820    Fax: 207-541-9138

Ronald M. Reilly, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd Ste 3, South Portland, ME 04106 Phone: 207-523-3700    Fax: 207-523-8590

William J. Ruth, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd Ste 3, South Portland, ME 04106 Phone: 207-523-8500    Fax: 207-523-8591

Julie E.o. Pelletier, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd Ste 3, South Portland, ME 04106 Phone: 207-523-3700    Fax: 207-523-8590

Dr. Amy C Sedgwick, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd, Suite 3, South Portland, ME 04106 Phone: 207-523-8500    Fax: 207-523-8591

Dr. Mary H. Becker, MD Emergency Medicine - Hospice and Palliative Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd Ste 3, South Portland, ME 04106 Phone: 207-523-8500    Fax: 207-523-8591

Dr. Amy F. Parker, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd Ste 3, South Portland, ME 04106 Phone: 207-523-8500    Fax: 207-523-8591

Eric S. Sampson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd, Ste 3, South Portland, ME 04106 Phone: 207-523-3700    Fax: 207-523-8590

Tammy W. Labonty, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 50 Foden Rd, Suite 3, South Portland, ME 04106 Phone: 207-523-8500    Fax: 207-523-8591

News Archive

Phase II trial of NUVIGIL Tablets for treatment of schizophrenia fails to meet primary endpoint: Cephalon

Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

João Gonçalves, from Faculdade de Farmácia e Instituto de Medicina Molecular, Lisbon, Portugal, to win a Grand Challenges Exploration Award

Study shows how gene mutations affect calcium pathway in arrhythmia

Using powerful X-rays, University of British Columbia researchers have reconstructed a crime scene too small for any microscope to observe - and caught the culprit of arrhythmia in action.

Recent advances in vaccine development for malaria, TB and HIV/AIDS

Collectively, malaria, TB & HIV/AIDS cause more than five million deaths per year - nearly the entire population of the state of Washington - and represent one of the world's major public health challenges as we move into the second decade of the 21st century.

Read more Medical News

› Verified 9 days ago